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CARMIL family proteins as multidomain 
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Department of Biochemistry and Molecular Biophysics and Department of Cell Biology and Physiology, 
Washington University School of Medicine, St. Louis, MO 63110
ABSTRACT CARMILs are large multidomain proteins that regulate the actin-binding activity 
of capping protein (CP), a major capper of actin filament barbed ends in cells. CARMILs bind 
directly to CP and induce a conformational change that allosterically decreases but does not 
abolish its actin-capping activity. The CP-binding domain of CARMIL consists of the CP-inter-
action (CPI) and CARMIL-specific interaction (CSI) motifs, which are arranged in tandem. 
Many cellular functions of CARMILs require the interaction with CP; however, a more surpris-
ing result is that the cellular function of CP in cells appears to require binding to a CARMIL or 
another protein with a CPI motif, suggesting that CPI-motif proteins target CP and modulate 
its actin-capping activity. Vertebrates have three highly conserved genes and expressed iso-
forms of CARMIL with distinct and overlapping localizations and functions in cells. Various 
domains of these CARMIL isoforms interact with plasma membranes, vimentin intermediate 
filaments, SH3-containing class I myosins, the dual-GEF Trio, and other adaptors and signaling 
molecules. These biochemical properties suggest that CARMILs play a variety of membrane-
associated functions related to actin assembly and signaling. CARMIL mutations and variants 
have been implicated in several human diseases. We focus on roles for CARMILs in signaling 
in addition to their function as regulators of CP and actin.
INTRODUCTION 
The dynamics of actin filament assembly and disassembly play im-
portant roles in many biological processes, both normal and patho-
logical (Pollard and Cooper, 2009). Actin filaments grow and shrink 
by addition and loss, respectively, of actin subunits at the ends of 
filaments. The barbed (plus) end of the filament is favored over the 
pointed (minus) end for assembly, both thermodynamically and 
kinetically (Pollard, 2016), and cells control their shape and migra-
tion by regulating barbed-end filament assembly spatially and tem-
porally (Shekhar et al., 2016). Examples of such regulation are 
numerous and affect a wide range of processes, including develop-
ment and differentiation (Harris et al., 2009), immunity and inflam-
mation (Marcos-Ramiro et al., 2014), and cancer cell invasion and 
metastasis (Kumar and Weaver, 2009; Mierke, 2013).
The growth of actin filament barbed ends by the addition of sub-
units is a major mechanism by which actin filaments form and as-
semble to do work in cells. A free actin subunit is able to add to a 
free barbed end on its own, and a number of factors that promote 
this process have been discovered and play important roles (Pollard, 
2016). In cells, the creation of free barbed ends correlates with and 
appears to be sufficient to induce actin filament polymerization 
(Bailly et al., 1999; Huang et al., 1999; Ghosh et al., 2004). Free 
barbed ends can be generated in several ways: de novo assembly 
of a new actin filament from free actin subunits, severing of an exist-
ing actin filament, and uncapping of the barbed end of a capped 
filament. Free barbed ends will stop growing if they are functionally 
capped, and capping is a feature of both termination and promo-
tion of actin assembly, depending on the context of polymerases 
and other regulators (Pollard, 2016).
One major mediator for capping the barbed end of filaments is 
capping protein (CP), an obligate α/β heterodimer found in essen-
tially all eukaryotic cells. A small number of direct-binding inhibitors 
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2014), and by a diverse set of proteins that contain a conserved 
capping protein interaction (CPI) motif (Hernandez-Valladares et al., 
2010; Edwards et al., 2014). CPI-motif proteins can remove CP from 
the barbed end (Edwards et al., 2014) and appear to be required for 
normal CP function (Edwards et al., 2015). This review focuses on 
the CPI-containing CP, Arp2/3, myosin-I 
linker (CARMIL) family of proteins and their 
roles as regulators of CP activity and scaf-
folding molecules for signaling pathways.
CARMIL-FAMILY PROTEINS
CARMIL-family proteins are large, highly 
conserved, multidomain homodimers. CAR-
MILs were discovered in Acanthamoeba 
(Acan125) and Dictyostelium (p116) based 
on direct binding of their proline-rich do-
main (PRD) to the Src homology 3 (SH3) do-
main of a subset of class I myosins (Xu et al., 
1995, 1997; Zot et al., 2000; Jung et al., 
2001). A myosin I SH3 domain was used as 
an affinity ligand in the purification of 
amoeba CARMILs from cells in a tight com-
plex with CP and Arp2/3 complex (Jung 
et al., 2001). Amoeba CARMILs possess 
verprolin-like and acidic regions that are 
capable of activating Arp2/3 complex for 
nucleation of actin polymerization (Jung et al., 
2001); however, these two regions do not 
appear to be present in vertebrate CARM-
ILs, and CARMIL1 does not appear to bind 
or activate Arp2/3 complex (Yang et al., 
2005; Liang et al., 2009).
Amoebozoa and invertebrates have one 
gene encoding CARMIL, whereas verte-
brates have three (Liang et al., 2009; Ed-
wards et al., 2014; Stark and Cooper, 2015), 
and the genomes of fungi and plants appear 
to lack CARMIL homologues altogether. The 
three vertebrate isoforms, CARMIL1, 2, and 
3, can be defined and distinguished from 
each other by conserved differences in their 
amino acid sequences (Figure 1).
CARMIL-protein domain architecture
Vertebrate CARMILs share a common do-
main architecture (Zwolak et al., 2013), illus-
trated in Figure 1. The N-terminus has a 
noncanonical pleckstrin-homology (PH) do-
main, followed by a leucine-rich repeat (LRR) 
domain. The PH and LRR domains are con-
nected by an apparently rigid linker; this 
linker and the N-cap region of the LRR 
domain contain conserved amino acid 
sequences that are highly distinctive for 
CARMILs, but they serve a function as yet 
unknown. These sequences have been used 
to aid in the identification of CARMILs from 
various organisms (Liang et al., 2009; Zwolak 
et al., 2013; Stark and Cooper, 2015). The 
LRR domain is followed by a helical dimer-
ization (HD) domain, and the C-terminal half 
of the protein consists of an extended 
Edwards et al., 2014), and in vitro, purified CP can be inhibited by 
phosphatidylinositol (4,5)-bisphosphate and other anionic phospho-
lipids (Heiss and Cooper, 1991; Kuhn and Pollard, 2007; Li et al., 
2012), by the protein V-1 (Bhattacharya et al., 2006; Fujiwara et al., 
FIGURE 1: Conservation and domain architecture of CARMIL proteins. (A) Domain architecture 
of CARMIL proteins, illustrating the arrangement of the PH domain, linker (L), N-cap (N), LRR 
domain, C-cap (C), HD, CBR consisting of a CPI motif and a CSI motif, MBD, and a PRD. 
Sequence alignment of the CBR for selected CARMILs, including the three vertebrate isoforms 
in zebrafish, mouse, and human (encoded by three separate genes). The alignment includes 
sequences for invertebrates, which lack the CSI motif region or lack residues known to be 
required for the CSI-CP interaction (Zwolak et al., 2010b). Shaded residues are identical to the 
consensus sequences. (B) Unrooted phylogenetic tree showing the relationships among CARMIL 
proteins, revealing five groups of CARMIL genes. Vertebrate genomes have three genes that 
encode three conserved isoforms—CARMIL1, CARMIL2, and CARMIL3—and invertebrates have 
a single CARMIL gene and isoform. Invertebrate CARMILs can be further classified into those 
that contain a CSI motif and those that do not.
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LRR domains are bounded by ends with distinct flanking se-
quences, referred to as N-cap and C-cap, respectively (Bella et al., 
2008; Zwolak et al., 2013; Dao et al., 2014). N-caps are believed to 
either stabilize the hydrophobic core or promote correct folding of 
the LRR domain (Bella et al., 2008; Dao et al., 2014). Among CARM-
ILs, the N-cap sequences are very similar to one another (Liang 
et al., 2009; Zwolak et al., 2013; Stark and Cooper, 2015). For this 
reason, the N-cap region has been useful in BLAST searches for 
CARMIL family members in the genomes of various organisms 
(Liang et al., 2009; Stark and Cooper, 2015), and it has been referred 
to as a CARMIL homology domain (CHD; Liang et al., 2009). Unlike 
the N-cap, the sequences of the C-caps are not conserved among 
CARMILs, nor are they similar to C-cap sequences in other LRR do-
mains; nevertheless, their secondary structure resembles that of the 
C-cap in the LRR domain of tropomodulin (Krieger et al., 2002; 
Zwolak et al., 2013).
Helical dimerization domain
CARMILs exist as homodimers in cells, and biochemical studies 
reveal that homodimerization is mediated by the HD domain of 
CARMIL (Zwolak et al., 2013). Isolated HD domains dimerize (Zwolak 
et al., 2013), and full-length CARMILs, purified or isolated from cells, 
are found as homodimers (Roncagalli et al., 2016; Wang et al., 
2016). The antiparallel nature of the dimer, revealed by small-angle 
x-ray scattering (SAXS) of mouse CARMIL1, indicates that dimeriza-
tion places the N-terminal PH domains in an orientation allowing 
both of them to interact with a planar structure, such as the plasma 
membrane (Liang et al., 2009). Indeed, the PH domain of CARMIL1 
is important for membrane localization in cells (Zwolak et al., 2013).
Homodimerization of CARMILs has been documented for 
Acanthamoeba CARMIL (Remmert et al., 2004), mammalian CAR-
MIL1 (Liang et al., 2009; Zwolak et al., 2013), and mammalian 
CARMIL2 (Roncagalli et al., 2016; Wang et al., 2016). Heterodi-
mers of CARMIL1 and CARMIL2 were not observed for human 
cells expressing the two isoforms at endogenous levels (Liang 
et al., 2009); however, heterodimers can be induced to form in 
small amounts when CARMILs are expressed at artificially high 
levels (Edwards, Lanier, and Cooper, unpublished data). The amino 
acid sequences of the HD domains of CARMIL1 and CARMIL3 are 
more similar to one another than to the sequence of the CARMIL2 
HD domain (Zwolak et al., 2013), raising the possibility that CAR-
MIL1-CARMIL3 heterodimers may form under physiological condi-
tions. However, structural models of HD homodimers based on 
SAXS lack the resolution to address this question, and heterodimer 
formation has not been properly investigated, either with purified 
proteins or in cells.
Capping protein–binding region
The CARMIL CBR is part of the extended intrinsically disordered 
C-terminal portion of the polypeptide that follows the HD do-
main. The CBR includes two conserved sequences in tandem 
termed the capping protein interaction (CPI) and CARMIL-specific 
interaction (CSI) motifs (Hernandez-Valladares et al., 2010; 
Figure 1). This region has also been called CAH3 (for CARMIL 
homology domain 3), and the portions corresponding to the CPI 
and CSI motifs have been called CAH3a and CAH3b, respectively 
(Zwolak et al., 2010b).
The CPI motif, with the consensus sequence LxHxTxxRPK(x)6P, is 
found in a diverse set of otherwise unrelated proteins, all of which 
bind directly to CP (Bruck et al., 2006). For CARMIL1 and CARMIL2, a 
number of cellular functions have been demonstrated to depend on 
intrinsically disordered region. The disordered region contains a CP-
binding region (CBR) made up of a CPI motif and a CARMIL-specific 
interaction (CSI) motif arranged in tandem, followed by a short basic 
and hydrophobic membrane-binding domain (MBD) and a proline-
rich domain (PRD) that binds SH3 domains of class I myosins and 
other proteins (Liang et al., 2009; Edwards et al., 2013; Zwolak et al., 
2013; Roncagalli et al., 2016). We discuss these domains in detail, 
with consideration for the differences between isoforms.
Pleckstrin-homology domain
The noncanonical PH domain was identified by biochemical and 
structural studies of mouse CARMIL1, including x-ray crystallog-
raphy (Zwolak et al., 2013). The PH domain binds monophos-
phorylated phosphatidylinositides—phosphatidylinositol 3-phos-
phate, phosphatidylinositol 4-phosphate, and phosphatidylinositol 
5-phosphate—with high specificity. In contrast to canonical PH 
domains, the residues important for phospholipid binding are 
not in the traditionally recognized lipid-binding pocket (Ferguson 
et al., 2000; Lemmon, 2007); instead, the key residues lie near 
the interface of the PH domain and the LRR domain (Zwolak 
et al., 2013). Removal of the PH domain from the CARMIL1 N-
terminus decreases the degree of plasma membrane localization 
in cells, confirming the physiological importance of phospholipid 
binding (Zwolak et al., 2013).
In contrast, the PH domain of CARMIL2 lacks the conserved resi-
dues needed for phospholipid binding, based on sequence align-
ments (Zwolak et al., 2013). As predicted, the CARMIL2 PH domain 
is not sufficient to target green fluorescent protein (GFP) to the 
plasma membrane (Lanier et al., 2015). For CARMIL3, the PH 
domain has not been studied experimentally, but its sequence is 
similar to that of CARMIL1, including the conservation of the phos-
pholipid-binding residues.
Leucine-rich repeat domain
LRRs, defined by the consensus sequence LxxLxLxx(N/C)xxL, are 
generally involved in protein–protein interactions (Kobe and Kajava, 
2001; Enkhbayar et al., 2004; Bella et al., 2008). In the crystal struc-
ture of mouse CARMIL1, the 16-repeat LRR assumes a horseshoe 
shape as found for other LRR domains (Kobe and Deisenhofer, 
1996; Zwolak et al., 2013). Within this horseshoe, the LRR adopts a 
typical structure, with α-helices on the convex surface and β-strands 
on the concave surface (Zwolak et al., 2013). Although the second-
ary structure features of the repeats are characteristic of LRR domains 
in general, the amino acid sequences of LRR domains in CARMILs 
are more similar to one another than to those in unrelated proteins 
(Kobe and Kajava, 2001), suggesting the possibility of functional 
differences rather than simple structural conservation.
The notion of distinct functions for CARMIL LRR domains is sup-
ported by studies in human cultured cells, in which CARMIL2 local-
izes to vimentin filaments via its LRR domain (Lanier et al., 2015). 
This conclusion is based on the finding that a chimeric protein in 
which the LRR comes from CARMIL2 and the remainder of the poly-
peptide is taken from CARMIL1 colocalizes with vimentin in cells 
and rescues the loss of CARMIL2 function. In contrast, the converse 
chimera, composed of the LRR domain of CARMIL1 fused with all 
other domains from CARMIL2, fails to localize with vimentin in cells 
and is unable to rescue the loss of CARMIL2 function (Lanier et al., 
2015). In this regard, the cellular functions of all the domains of CAR-
MIL 1 and 2 other than the LRR domain can be considered as over-
lapping. This conclusion is necessarily limited to the setting of the 
cell culture assays and cell types examined.
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sembly, capping barbed ends is necessary for the reconstitution of 
actin polymerization and actin-based motility from purified compo-
nents (Loisel et al., 1999). In the case of formin-nucleated actin 
assembly, CP and formins antagonize each other functionally (Bre-
itsprecher and Goode, 2013), and they can simultaneously bind to 
the barbed end of an actin filament, forming a so-called decision 
complex. The decision complex resolves with either capping of the 
filament by CP and dissociation of formin from the tip, or removal of 
CP from the barbed end, followed by formin-mediated actin polym-
erization (Bombardier et al., 2015; Shekhar et al., 2015). Both 
Arp2/3- and formin-mediated actin polymerization presumably rely 
on CP to limit the length of the actin filaments and help to maintain 
a pool of free actin monomers.
The second implication of the foregoing biochemical observa-
tions is that CARMILs may modulate the capping activity of CP, 
“tuning it down” to levels that are physiologically relevant for the 
cytoplasmic concentrations of CP and barbed ends (Yang et al., 
2005; Uruno et al., 2006; Hernandez-Valladares et al., 2010; Kim 
the ability of the motif to bind CP (Edwards et al., 2013, 2014; Lanier 
et al., 2015). Two cocrystal structures of CP, one in complex with the 
full CBR of CARMIL1 and the other with the CPI motif of CD2AP, re-
vealed a conserved set of close contacts between the CPI motifs and 
CP (Hernandez-Valladares et al., 2010; Takeda et al., 2010).
In contrast to the more common CPI motif, the CSI motif (con-
sensus sequence RxDEGxEEFFxKR; Hernandez-Valladares et al., 
2010; Zwolak et al., 2010b) is present only in proteins of the CARMIL 
family. Moreover, the CSI is limited to CARMILs from vertebrates 
and higher invertebrates; CARMILs from lower eukaryotes, includ-
ing Acanthamoeba, Dictyostelium, and Caenorhabditis, lack the 
consensus sequence (Figure 1; Zwolak et al., 2010b; Edwards et al., 
2014). Whereas the CPI motif on its own is sufficient to bind to CP 
and decrease its actin-binding activity, the CSI motif binds CP 
weakly and has relatively little ability to inhibit its activity. Neverthe-
less, as part of the CBR, the CSI makes an important contribution to 
the binding and inhibition of CP (Hernandez-Valladares et al., 2010; 
Zwolak et al., 2010b).
Actin and the CBR bind to distinct sites on the mushroom-
shaped CP α/β heterodimer. The barbed end of the actin filament 
binds to the top surface of the mushroom (Narita et al., 2006; Kim 
et al., 2010), whereas the CBR binds to the mushroom stalk via its 
CPI and CSI motifs (Hernandez-Valladares et al., 2010; Takeda et al., 
2010). The CPI motif binds along the surface of about half of the 
perimeter of the mushroom stalk, covering parts of both the CP α- 
and β-subunits. Contact residues between CPI and CP, identified in 
the cocrystal structure (Hernandez-Valladares et al., 2010; Takeda 
et al., 2010), have been documented to be important for this inter-
action in biochemical and cell biological assays (Edwards et al., 
2013, 2015; Lanier et al., 2015).
The short linker sequence that connects the CPI and CSI motifs 
was not resolved in cocrystal structures, suggesting that it may not 
bind residues on the surface of CP (Hernandez-Valladares et al., 
2010). Replacing the residues of the linker sequence with a set of 
alternating Ala and Gly residues did not affect the ability of the CBR 
to bind and inhibit CP activity in actin-capping assays (Kim et al., 
2012), confirming the absence of functionally important close con-
tacts in this region. However, it remains possible that the physical 
properties of the linker affect the kinetics and thermodynamics of 
CBR binding through effects on the physical properties of the intrinsi-
cally disordered domain, including the adjacent CPI and CSI motifs.
The binding of CARMIL to CP has an allosteric effect on the con-
formation of CP’s actin-binding surface. CARMIL binding promotes 
occupancy of a CP state that is more similar to unbound CP than to 
actin-bound CP (Figure 2). This state has structural and dynamic 
properties that decrease the binding affinity of CP for the barbed 
end of the actin filaments (Hernandez-Valladares et al., 2010; Kim 
et al., 2012; Edwards et al., 2013). Evidence for this conclusion in-
cludes the observation that the CBR domain of CARMIL decreases 
the actin capping activity of CP by 250-fold (Kim et al., 2012). In ad-
dition, CBR binding leads to an increase in the dissociation rate of 
CP from the barbed end, suggesting that a molecule of CBR can 
bind to a molecule of CP bound to a capped actin filament, forming 
a trimolecular complex (Fujiwara et al., 2010; Hernandez-Valladares 
et al., 2010; Kim et al., 2012; Lanier et al., 2015). This is an important 
point, relevant to cellular function—CARMIL binding to CP decreases 
but does not abolish the capping activity of CP, and this trimolecular 
complex can exist in vitro and, presumably, in vivo (Yang et al., 2005).
These biochemical observations have two potential implications 
for the function of CARMIL (and other CPI proteins) in cells. First, 
CARMIL may recruit or target the barbed-end capping activity of CP 
to a site of actin assembly. In the case of Arp2/3-nucleated actin as-
FIGURE 2: Principal component analysis (PCA) of CP. Top, PCA of 
molecular dynamics simulations of the structural conformations of CP. 
The simulations were begun with CP that was either free (gray 
contour shading), bound to F-actin (blue dots and contour lines), or 
bound to CARMIL (red dots and contour lines). The results were 
projected onto the same conformational space; existing CP structures 
were overlaid as green dots. Based on this analysis, CARMIL-bound 
CP exists in a conformational space more like that of unbound CP 
(gray) than to that of F-actin–bound CP. Bottom, overlay of protein 
structures, depicting the conformations that correspond to the peaks 
of CARMIL-bound and F-actin bound CP. This analysis supports the 
findings that CARMIL allosterically inhibits CP by eliciting changes to 
the actin-binding surface, holding CP in a conformation similar to the 
free state. Used with permission from Kim et al. (2012).
Volume 28 July 1, 2017 CARMIL function | 1717 
For CARMIL1 and CARMIL3, the necessity of the MBD for func-
tion in cells has not been investigated directly. However, for CAR-
MIL1, observations from the literature strongly suggest that the 
MBD is important. Specifically, two studies, using different ap-
proaches to examine the function of CARMIL1 mutants deficient for 
CP binding, provide evidence for MBD function as well. In the first 
study, a CARMIL1 mutant with a 123-amino acid internal deletion 
that encompasses both the CBR and the MBD failed to rescue cell 
migration phenotypes of CARMIL1-depleted cells in wound-healing 
assays (Yang et al., 2005). In the second study, a CARMIL1 CP-bind-
ing mutant with substitutions for two highly conserved residues of 
the CPI consensus sequence, leaving both the CSI motif and the 
MBD intact, was largely able to rescue the wound-healing cell 
migration phenotype in CARMIL1-depleted cells (Edwards et al., 
2013). One key difference between the CARMIL1 mutant constructs 
in the two studies is the presence of the MBD in the expression 
construct for the latter but not the former. Taken together, these 
studies support the hypothesis that the MBD is necessary for the 
cellular function of CARMIL1, consistent with the results obtained 
for CARMIL2 described earlier.
The MBDs of different CARMIL isoforms have functions that are 
sufficiently similar as to be interchangeable in cells in some settings. 
As discussed earlier, the MBD of CARMIL1 was able to substitute for 
that of CARMIL2 in a chimera consisting of the PH domain of CAR-
MIL1, the LRR domain of CARMIL2, and the C-terminal half of CAR-
MIL1 (including the CBR and MBD), rescuing cellular phenotypes 
caused by depletion of endogenous CARMIL2 (Lanier et al., 2016).
The presence of the MBD and the CSI motif is a distinctive fea-
ture of CARMILs among the diverse and otherwise unrelated set of 
CPI motif–containing proteins (Lanier et al., 2016). Thus the MBD 
and the CSI motif may provide functions that distinguish the cellular 
roles of CARMILs from those of other CPI-motif proteins. The close 
proximity of the MBD to the CBR, which includes both CPI and CSI 
motifs, raises the possibility that the function of the MBD is to target 
regulation of CP and actin assembly to the vicinity of the membrane 
(Lanier et al., 2016).
Proline-rich domain
The C-terminal domains of CARMILs are rich in proline residues. 
Indeed, the initial discoveries of CARMILs in Acanthamoeba and 
Dictyostelium were based on direct physical interactions between 
the PRDs of CARMILs with the SH3 domains of the tails of certain 
class I myosins (Xu et al., 1995, 1997; Zot et al., 2000; Jung et al., 
2001). Acanthamoeba and Dictyostelium CARMILs have their CBR 
at the extreme end of the C-terminus, and they lack the extended 
C-terminal PRD seen in vertebrates (Figure 1); however, PxxP motifs 
responsible for SH3 binding are present just upstream of the CBR 
(Xu et al., 1995, 1997; Zot et al., 2000; Jung et al., 2001).
In vertebrates, the CARMIL1 PRD binds to myosin-IE, a class I 
myosin with an SH3 domain in its tail (Liang et al., 2009). Whereas 
CARMIL1 PRD has many PxxP motifs, the one(s) critical for SH3 
binding have not been identified. The physiological importance of 
this interaction has not been assessed; however, the tail domain of 
myosin-IE appears to stabilize focal adhesions at the leading edge 
of migrating cells (Gupta et al., 2013).
CARMIL2 does not bind to myosin-IE, based on a direct compari-
son with CARMIL1 (Liang et al., 2009). However, the CARMIL2 PRD 
includes 10 PxxP motifs, and it interacts with the signaling adaptor 
GRB2, which contains two SH3 domains. This interaction with GRB2 
appears to couple CARMIL2 to CD28 signaling (Roncagalli et al., 
2016), as discussed later. One can imagine that future studies will 
uncover other binding partners for the PRDs of CARMILs.
et al., 2012; Lanier et al., 2015). Consistent with this model, when 
the CBR-CP complex binds to actin barbed ends in vitro, CP dissoci-
ates from the barbed end at a faster rate, similar to the time frame 
for interactions of CP with the actin cytoskeleton in cells (Miyoshi 
et al., 2006; Fujiwara et al., 2010). This action of CARMIL may con-
tribute to the disassembly and turnover of actin filaments in cells by 
making the capping of barbed ends more dynamic.
The potential models of “targeting” CP and “tuning” its cap-
ping activity are not exclusive and may both exist in cells. The 
relevance of these models is supported by the cellular pheno-
types of a CP point mutant that is unable to bind to CPI motifs 
(Edwards et al., 2015). Although this mutant has normal actin-
capping activity in biochemical assays, it provides little or no 
actin-related function in cells. Dominant-negative and expression-
rescue approaches showed that the CP mutant phenocopies the 
simple loss of CP. These findings led to the conclusion that CP 
function in cells depends on an interaction with a protein that 
contains a CPI motif.
CP can be inhibited by the protein V-1 in vitro, and V-1 binds to 
the actin-binding surface of CP, acting as a direct competitor for the 
capping of barbed ends (Bhattacharya et al., 2006; Takeda et al., 
2010; Zwolak et al., 2010a; Fujiwara et al., 2014). If CP is inhibited by 
the binding of V-1 in cells, as revealed by a study with Dictyostelium 
(Jung et al., 2016), then one attractive model is that CARMILs, along 
with other proteins containing CPI motifs, activate rather than inhibit 
CP, as first suggested by Fujiwara et al. (2014). In this model, activa-
tion of CP is a consequence of a CPI-motif protein binding to the 
CP/V-1 complex, increasing the rate of V-1 dissociation by the same 
allosteric mechanism that decreases actin capping and promotes 
uncapping (Takeda et al., 2010; Fujiwara et al., 2014; Edwards et al., 
2015).
Membrane-binding domain
CARMILs have membrane-binding domains that consist of unstruc-
tured protein regions with basic and hydrophobic residues. This 
type of membrane-binding domain binds to lipid bilayers through a 
combination of electrostatic and hydrophobic interactions (Heo 
et al., 2006). In this context, binding requires a high density of basic 
and hydrophobic residues, but it is largely independent of the exact 
sequence (Papayannopoulos et al., 2005; Heo et al., 2006; Brzeska 
et al., 2010). A search algorithm designed to detect amino acid se-
quences with these features identified one in mouse CARMIL1, and 
the predicted region was found to bind to acidic phospholipids with 
a binding affinity in the micromolar range (Brzeska et al., 2010). This 
initial study used in vitro lipid-binding assays and a relatively large 
fragment of mouse CARMIL1. Later, smaller fragments of human 
CARMIL1, CARMIL2, and CARMIL3 containing the MBDs were 
found to be sufficient to target GFP to the plasma membrane in 
cells, including to the leading edge of migrating cells, which is an 
active site of actin polymerization (Lanier et al., 2016).
These studies showed that the CARMIL MBD is sufficient for 
membrane and lipid binding. In addition, the MBD has been shown 
to be necessary for membrane localization of full-length CARMILs 
in cells and is also required for the function of CARMIL in cells. Spe-
cifically, for CARMIL2, a series of point mutations in the MBD re-
vealed that the MBD is essential for membrane localization and for 
function (Lanier et al., 2016). Both full-length CARMIL2 and the C-
terminal half alone required the MBD for their membrane localiza-
tion in cells. For full-length CARMIL2, the MBD was required to 
rescue the phenotypes caused by the loss of endogenous CAR-
MIL2, revealing its requirement for CARMIL2 function within cells 
(Lanier et al., 2016).
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Collectively the expression studies reveal that the three CARMIL 
isoforms have isoform-specific expression patterns, but that, in some 
cases, two or three isoforms are found within the same cells and tis-
sues. For example, several human cultured cell lines express all three 
CARMIL isoforms (Liang et al., 2009). Further studies of the expres-
sion of CARMIL proteins within organisms would have value, in part 
to address apparent inconsistencies among previous studies.
Cellular functions of CARMILs
Because CARMILs are large, multidomain proteins, one might ex-
pect them to play multiple roles within cells. Indeed, although the 
CBR domain and actin-based functions have received the most 
attention, recent studies reveal roles in signaling networks and in hu-
man disease that may involve additional CARMIL domains (Table 1).
Regulation of actin assembly via CP. CARMILs contain CPI motifs; 
therefore their actin-related cellular functions need to be considered 
in the context of the otherwise-unrelated proteins with CPI motifs, 
as previously reviewed (Edwards et al., 2014). All CPI-motif proteins 
localize to membranes and may serve as scaffolds for the recruitment 
and activation of CP at sites of actin assembly. The physiological 
importance of the CPI motif–CP interaction in cells has been 
demonstrated for several of these proteins. For CD2AP, a rescue 
construct bearing mutations that affect CPI residues fails to rescue 
CP localization in CD2AP-null cells (Zhao et al., 2013). For CKIP-1, 
interactions between the CPI motif and CP are required for increases 
in levels of cellular actin and F-actin caused by overexpression 
(Canton et al., 2006). For both CARMIL1 (Edwards et al., 2013) and 
CARMIL2 (Lanier et al., 2015), loss of CPI-CP interactions results in 
phenotypes reminiscent of the loss of CP function or localization.
In addition to the aforementioned studies investigating the role 
of the CPI residues in the interaction with CP, a complementary 
study probed CP residues for their relevance by alanine substitu-
tions for two CP β-subunit residues in close contact with CPI in co-
crystal structures (Hernandez-Valladares et al., 2010; Edwards et al., 
2015). This mutant CP retained its full actin-binding capability; how-
ever, when expressed in cells, it mimicked the phenotype of loss of 
function of CP (Edwards et al., 2015). This study concluded that CP 
requires an interaction with a CPI-motif protein to function.
On the other hand, the CPI motifs of CARMIL1 or CARMIL2 do 
not appear to be necessary for all cellular functions. In particular, cell 
migration during wound-healing assays with cultured fibroblasts 
showed little dependence on the CPI motif (Edwards et al., 2013; 
Lanier et al., 2015). Similarly, in T-cells, the CARMIL2 CPI motif was 
not required for the CARMIL2 functions in CD28 costimulation and 
downstream signaling during T-cell activation (Roncagalli et al., 2016).
ROLES OF CARMILS AT THE CELLULAR AND 
ORGANISMAL LEVELS
CARMIL expression during development and differentiation
The patterns and timing of expression of CARMIL isoforms in verte-
brate cells and tissues have been addressed, but only to a limited 
extent (Table 1). As noted earlier, vertebrates have three genes from 
which three highly conserved isoforms of CARMIL are expressed 
(Figure 1).
In zebrafish, the three isoforms show distinct spatial and tempo-
ral expression patterns through development and differentiation 
(Stark and Cooper, 2015). Of the three, CARMIL1 is most widely 
expressed, being present in the skin, fins, branchial arches, gut, and 
cloaca (Stark and Cooper, 2015). An RNA-sequencing study of ze-
brafish skin found only the CARMIL1 isoform ( Wang, Cokus, and 
Sagasti, personal communication). CARMIL2 is expressed at high 
levels in brain and spinal cord and at lower levels in eye and devel-
oping kidney (Trinh et al., 2011; Stark and Cooper, 2015). CARMIL3 
is expressed at high levels in brain and eye, with lower levels in the 
spinal cord. It is also expressed in the developing heart and is the 
only isoform observed in this organ (Stark and Cooper, 2015).
Studies of the expression of CARMIL isoforms in other verte-
brates have been more limited. An analysis of five isolated mouse 
tissues revealed that CARMIL1 was highly expressed in testis and 
weakly in spleen and brain; CARMIL2 was highly expressed in thy-
mus and spleen and weakly in bone marrow; and CARMIL3 was ex-
pressed in brain and testis (Liang et al., 2013). In a study of human 
tissues, CARMIL2 expression, assayed by reverse transcription PCR 
(RT-PCR), was detected in 30 different tissues, including skin (Matsu-
zaka et al., 2004). A study of CARMIL3 expression in human cells 
identified it as an oncofetal gene; it was found in brain, colon, heart, 
kidney, liver, lung, skeletal muscle, and spinal cord of both adult and 
fetal tissue samples, based on RT-PCR assays (Hsu et al., 2011).
The patterns of expression of CARMIL isoforms in vertebrates 
can also be obtained from the RNA-sequencing and microarray data 
curated in the Expression Atlas at the European Bioinformatics Insti-
tute (Kapushesky et al., 2012; Petryszak et al., 2014). In spite of cer-
tain inconsistencies across data sets, even for the same organism 
and tissue, several trends are clear. First, CARMIL1 is the most 
widely expressed isoform, detectable within a variety of tissues 
across multiple species. Analyses of skin revealed CARMIL1 expres-
sion in sheep (Bakhtiarizadeh et al., 2016), mice (Huntley et al., 
2016), and humans (FANTOM Consortium and the RIKEN PMI and 
CLST (DGT) et al., 2014; Uhlen et al., 2015; Human Protein Atlas 
[www.proteinatlas.org]). Second, CARMIL2 and CARMIL3 are the 
isoforms most commonly expressed in brain tissues across a variety 




Invertebrate NA NA Decreased NF-κB signaling NA
CARMIL1 Skin, testis, spleen CP regulation, 
macropinocytosis
Wound healing, increased Trio 
signaling
Gout, ARDS
CARML2 Brain, spinal cord, kidney, 
thymus, spleen, bone 
marrow, eyes
CP regulation, cell polarity Wound healing, CD28-mediated 
T-cell activation, increased NF-κB 
signaling
Immune function, T-cell 
development
CARMIL3 Brain, eyes, spinal cord, 
heart, testis
NA NA Oncofetal gene
NA, not available.
TABLE 1: Summary of CARMIL functions in cells and organisms.
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CARMIL proteins in human disease. CARMIL genes and proteins 
have been implicated in several human diseases. A variant of the 
gene encoding CARMIL1 (LRRC16A) has been associated with 
increased susceptibility to gout (Kolz et al., 2009; Sakiyama et al., 
2014). This led to the proposal that CARMIL1-based regulation 
of CP, and thus of actin, influences the function of the urate-
transporting macromolecular complex through an unknown 
mechanism (Sakiyama et al., 2014).
CARMIL1 variants have also been implicated in acute respiratory 
distress syndrome (ARDS; Wei et al., 2015, 2017); single-nucleotide 
polymorphisms (SNPs) have been associated with blood platelet 
count, an important parameter of clinical outcome. One SNP, stud-
ied in detail, causes a single–amino acid change in the LRR domain, 
decreased expression of mRNA, increased patient survival, and a 
decreased rate of platelet loss during the course of the illness (Wei 
et al., 2017). One potential scenario is that decreased CARMIL1 
function impairs the actin cytoskeleton of the platelet, which lessens 
platelet activation and therefore mitigates the loss of circulating 
blood platelets. Paradoxically, poor platelet function has a beneficial 
effect for the ARDS patient because loss of platelets is a critical neg-
ative determinant.
In the case of the CARMIL2 gene (RLTPR), three studies identified 
mutations in families with primary immunodeficiencies (Sorte et al., 
2016; Wang et al., 2016; Schober et al., 2017). In one of these stud-
ies, a missense mutation affecting the LRR domain (L603H) was 
found in four patients from three Norwegian families. The patients 
presented with warts, molluscum contagiosum, dermatitis, and evi-
dence of immune dysfunction and susceptibility to viral infection in 
other systems (Sorte et al., 2016). In these individuals, levels of regu-
latory and CD4+ T-cells were low, as was the synthesis of interferon-γ 
in CD4+ T-cells and NK cells.
In the second study of CARMIL2, three point mutations (L372R, 
L489Q, and Q817X) were found in six individuals from three families 
(Wang et al., 2016). Homozygous individuals experienced mucocuta-
neous infections associated with decreased levels of regulatory and 
memory CD4+ T-cells as well as memory B-cells. The latter were un-
able to activate NF-κB after stimulation of B-cell receptors, indicating 
that B-cell dysfunction was independent of activation by CD4+ T-cells 
(Wang et al., 2016). Two of the mutations (L372R and L489Q) affect 
the LRR domain of CARMIL2, and the third (Q817X) introduces a stop 
codon in the HD domain. The missense alleles are associated with 
low levels of CARMIL2 protein, and the nonsense allele is expected to 
produce a truncated protein that lacks important functional domains 
in the intrinsically disordered C-terminal half of the protein.
In a third study of immunodeficiencies caused by CARMIL2 mu-
tations, nonsense mutations in the linker/N-cap region or the N-
terminal half of the LRR domain affected CD28-based activation, 
development, and function of T-cells (Schober et al., 2017). Patients 
lacked regulatory T-cells and suffered from immunodeficiency syn-
dromes similar to those in patients in the studies discussed earlier 
(Sorte et al., 2016; Wang et al., 2016; Schober et al., 2017). In T-cells 
isolated from patients, levels of F-actin at the leading edge were 
decreased and the microtubule network was disorganized. When 
migrating, the T-cells were often multipolar, with decreased directed 
motion (Schober et al., 2017), reminiscent of the effects of CARMIL2 
knockdown in a cultured cell line (Liang et al., 2009). These muta-
tions also resulted in decreased activation of NF-κB signaling 
(Schober et al., 2017).
Overall these three studies of human patients suggest that the 
effects of CARMIL2 mutations in are likely related to the role of 
CARMIL2 in CD28 costimulation and T-cell development, as dis-
cussed earlier.
CARMIL proteins as signaling scaffolds
NF-κB signaling pathway. In insects, treatment with a nicotinic ace-
tylcholine receptor agonist, clothianidin, leads to increased expres-
sion of the single CARMIL gene (in flies, Dmel/LRR; in bees, Amel/
LRR), and this leads to a decrease in NF-κB activation (Di Prisco 
et al., 2013). This deficiency in NF-κB activation was found to 
account for an increase in the effects of pathogens on insects previ-
ously exposed to neonicotinoids such as clothianidin. In this setting, 
CARMIL functions as a negative regulator of NF-κB signaling down-
stream of receptor-based signaling.
Signaling promoting T-cell development. In higher organisms, 
CARMIL2 (also known as RLTPR) contributes to the immune system 
by controlling the development of certain T-cell subsets: Tregs and 
effector memory CD4+ T-cells (Liang et al., 2013; Roncagalli et al., 
2016; Sorte et al., 2016; Wang et al., 2016). Within murine T-cells, 
CARMIL2 is required for proper localization of PKCθ and CARMA1 
after CD28 stimulation (Liang et al., 2013). This study identified a 
point mutation that affects the mouse CARMIL2 LRR domain 
(RltprBas) and abrogates the effects of CD28 stimulation while 
retaining the CP-binding activity of CARMIL2. Ligand-induced CD28 
internalization was accelerated in cells expressing the mutant CAR-
MIL2, presumably due to decreases in “drag” resulting from loss 
of interactions with PKCθ, CARMA1, and downstream molecules 
(Liang et al., 2013; Roncagalli et al., 2016). CARMIL2 was required 
for the production of interleukin-2 downstream of the CD28 signal-
ing pathway; this required its PH, LRR, and PRD domains, but the 
CP-binding activity of the CPI motif was dispensable (Roncagalli 
et al., 2016). Of interest, another CPI-motif protein, CapZIP, was 
found to be required, suggesting that the presence of the CPI motif 
of CapZIP allows for the loss of the CARMIL2 CPI motif (Tian et al., 
2015; Roncagalli et al., 2016).
Rho-family GTPase signaling pathway. Several studies have impli-
cated CARMIL in Rac signaling via the dual–guanine nucleotide ex-
change factor (GEF) protein Trio. First, the single CARMIL gene in 
Caenorhabditis elegans (CRML-1) was detected in a genetic screen 
for inhibitors of the migration of neurons and axon growth cones 
(Vanderzalm et al., 2009). Genetic and biochemical interactions 
revealed that the inhibitory effect of CARMIL was mediated by Trio 
(UNC-73; Vanderzalm et al., 2009). A subsequent genetic study, 
investigating epithelial intercalation in the epidermis of this organ-
ism, also revealed that CARMIL inhibits Trio (Walck-Shannon et al., 
2015). In this case, loss of CARMIL, and thus loss of Trio inhibition, 
led to loss of the polarized actin-rich protrusions that are required 
for intercalation among epithelial cells. In both studies, CARMIL 
functioned as a net negative regulator of Rac and RhoG, proteins 
that are activated by Trio’s GEF domains and promote Arp2/3- 
mediated actin polymerization (Walck-Shannon et al., 2015).
In cultured human cells, loss of CARMIL1, but not CARMIL2, led 
to the loss of Rac1 activation that occurs when cells spread on a 
fibronectin-coated substrate (Liang et al., 2009). In that study, Trio 
also interacted biochemically with CARMIL1 but not with CARMIL2. 
Later, the ability of CARMIL1 to enhance Rac1 activation was found 
to be independent of the ability of CARMIL1 to bind CP (Edwards 
et al., 2013). These results for CARMILs in humans and worms differ 
in one paradoxical respect. Whereas in human cells, the effect of 
CARMIL1 on Rac1- and Arp2/3-mediated actin assembly was posi-
tive, in worms, the net effect of CARMIL was negative. This discrep-
ancy in outcome may reflect differences in the organisms, including 
the fact that humans have three CARMIL isoforms, which have both 
distinct and overlapping functions (Walck-Shannon et al., 2015).
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the proteins—the CBR of Acanthamoeba CARMIL is at the C-termi-
nus and lacks the CSI-motif, whereas the CBR of mouse CARMIL1 is 
separated from the C-terminus by ∼300 amino acid residues and 
contains the CSI motif. Of course, differences in solution and other 
conditions may also affect the accessibility of the CBR in the full-
length protein because the C-terminal regions of both proteins are 
intrinsically disordered.
We next consider and propose models with additional details for 
vertebrate CARMIL1 and CARMIL2, based on findings from pub-
lished studies. For CARMIL3, the paucity of published data prevents 
a detailed discussion of models. The domain structure of CARMIL3 
is similar to those of CARMIL1 and CARMIL2; however, the isoforms 
display conserved sequence differences that suggest the presence 
of distinct functions.
Model for CARMIL1. This model proposes that CARMIL1 
homodimers are transported to the plasma membrane along actin 
filaments. Class I myosins, namely myosin-1E and myosin-1F, bind 
PxxP motifs of CARMIL1’s PRD via their SH3 domains, and they carry 
CARMIL1 toward the membrane-associated barbed ends of actin 
filaments (Figure 3). The PH domain and MBD of CARMIL1 then 
bind directly to membrane lipids. Arp2/3 complex is activated at 
or near the membrane by signals from receptors transduced 
by small GTPases. Arp2/3 nucleates actin 
polymerization, and its branched network 
of actin filaments requires CP for proper 
assembly and force production.
In this model, CP is recruited to the 
membrane by CARMIL1. Binding of CAR-
MIL1 to CP promotes dissociation of the CP 
inhibitor V-1, which activates CP for barbed-
end capping. In addition, the fact that CP is 
bound to CARMIL1 provides for capping 
with kinetic rate constants and binding af-
finities that are relevant to the time scale of 
actin-based motility and the physiological 
concentrations of the reacting. Experimen-
tal evidence supports the existence of a 
pool of CP/V-1 complex in cells; most of the 
cellular population of CP is bound to V-1 
(Fujiwara et al., 2014), and modeling studies 
suggest that a pool of CP diffuses slowly 
(McMillen and Vavylonis, 2016).
While at the membrane, CARMIL1 also 
interacts with the dual-GEF Trio, promoting 
signaling by RhoG, Rac1, and/or RhoA. The 
resulting increase in Rac1 activity promotes 
actin assembly by positively regulating the 
WAVE complex, creating a positive feed-
back loop for Arp2/3-mediated actin nucle-
ation (Figure 3).
Model for CARMIL2. Certain aspects of 
the model proposed for CARMIL2 function 
resemble those of CARMIL1, including the 
ability to recruit and regulate CP to promote 
cell migration, lamellipodial assembly, 
membrane ruffling, and macropinocytosis, 
based on the loss-of-function phenotypes 
for CARMIL1 and CARMIL2. Overlapping 
functions for CARMIL1 and CARMIL2 were 
also suggested by the observation that a 
Molecular models of CARMIL function in cells
Here we consider working models for CARMIL function in cells as a 
framework for current knowledge and a basis for future studies. The 
biochemical, structural, and cellular properties of CARMIL proteins 
suggest that they interact with signaling networks to regulate the 
dynamics of the actin cytoskeleton at membranes. CARMILs move 
to the membrane either by passive diffusion or active transport. 
Once near the membrane, CARMILs may bind directly to mem-
brane lipids and then recruit and/or inhibit CP via their CBR do-
mains, as well as interact with signaling molecules.
One open question is whether the CBR domains of full-length 
CARMILs are found in an autoinhibited state in cells. In the case of 
Acanthamoeba CARMIL, a set of biochemical experiments with pu-
rified proteins provided compelling evidence that autoinhibition 
does occur (Uruno et al., 2006). In that study, a C-terminal fragment 
of CARMIL, which included the CBR, bound to CP with ∼20-fold 
greater affinity than did full-length CARMIL. Moreover, mild proteo-
lytic cleavage of full-length CARMIL generated the more active C-
terminal fragment. On the other hand, in a separate study with 
mouse CARMIL1, full-length CARMIL1 and its CBR fragment were 
similarly effective in actin polymerization-based assays measuring 
CP inhibition (Yang et al., 2005). The difference in the results from 
the two studies may be attributable to a notable difference between 
FIGURE 3: Models for CARMIL1 and CARMIL2 function within cells. (A) CARMIL1 is transported 
to the membrane via myosin-IE. CARMIL1 interacts with the membrane via PH domain and 
MBD. At the membrane, CARMIL1 recruits CP and relieves it from inhibition by V-1. Released 
V-1 then activates NF-κB signaling. CARMIL1 also activates Trio, which leads to an increase in 
Rac1 activation and Arp2/3-mediated actin assembly. (B) CARMIL2 is transported to the 
membrane via an interaction with vimentin filaments, where it then associates with the 
membrane via its MBD. In migrating cells, the CARMIL2 model is similar to CARMIL1 in that the 
CBR interacts with CP bound by V-1. This activates CP, allowing for barbed-end capping. 
(C) During CD28 costimulation to activate T-cells, membrane-localized CARMIL2 interacts with 
the adaptor protein GRB2, leading to downstream activation of CARMA1, PKCθ, and NF-κB 
activation.
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with vimentin filaments within the cell, and it may mediate the ef-
fects of vimentin filaments on actin assembly at membranes.
It is likely that many functions of CARMILs remain to be identi-
fied. Indeed, the effects of mutations in model organisms and hu-
man patients have only recently come to light. In terms of human 
disease, mutations of CARMIL1 and CARMIL2 have been implicated 
in several different disorders. Much also remains to be learned 
about the functional implications of the interactions of CARMILs 
with known binding partners. Finally, the functions of many of the 
CARMILs domains are not yet known. This new information will be 
important for understanding the molecular mechanisms of a diverse 
set of biological and pathological processes, many of which depend 
on the function of the actin cytoskeleton.
chimera consisting of the PH domain of CARMIL1, the LRR domain 
of CARMIL2, and the C-Terminal half of CARMIL1 (including the 
CBR and MBD), rescues cellular phenotypes caused by the depletion 
of endogenous CARMIL2 (Lanier et al., 2015)
Transport of CARMILs 1 and 2 to the membrane are likely to dif-
fer. Only CARMIL1 associates with myosin 1E (Liang et al., 2009), 
and only CARMIL2 associates with dynamic vimentin filaments 
(Liang et al., 2009; Lanier et al., 2015). Thus vimentin filaments may 
carry CARMIL2 toward the membrane by interacting with its LRR 
domain (Figure 3), for which the biochemical mechanism is not yet 
understood.
At the membrane of migrating cells, CARMIL2 is proposed to 
contribute to actin assembly by regulating CP in the manner 
described for CARMIL1 (Figure 3). However, both CARMIL1 and 
CARMIL2 are necessary for lamellipodial dynamics and ruffling, 
and neither protein is able to rescue the loss of the other, reveal-
ing that certain aspects of their function must be distinct (Liang 
et al., 2009). CARMIL2 is known to differ from CARMIL1 in ways 
that are potentially important for regulation of actin assembly. Un-
like CARMIL1, CARMIL2 does not contribute to Rac1 activation, 
but it does affect the level of expression of myosin-IIB (Liang 
et al., 2009).
CARMIL2 plays a scaffolding role in T-cell development, which 
does not require the function of the CPI motif and is thus indepen-
dent of CP-based regulation of actin. Instead, this role requires the 
PH, LRR, and PRD domains of CARMIL2 (Roncagalli et al., 2016; 
Wang et al., 2016). This role may involve CARMIL2-interacting pro-
teins such as transmembrane receptors (CD28 and CD8B), GEFs 
(VAV1 and DOCK8), phosphatases (PRPRF, PRPRC, and PTPN6), 
adaptor proteins (FYB, SIT1, GRAP2, GRB2, and Carma1), and a 
GAP (RASL3; Roncagalli et al., 2016). During CD28 costimulation of 
T-cells, CARMIL2 is recruited to the activated receptor and binds an 
adaptor protein (GRB2 or GRAP2). Here CARMIL2 serves as a bind-
ing partner for CARMA1, which activates protein kinase Cθ (PKCθ) 
and thus leads to NF-ΚB activation, thereby promoting the activa-
tion and proliferation of T-cells (Figure 3).
These models suggest that CARMIL1 and CARMIL2 activate NF-
κB signaling; however, as described earlier, work in insects shows 
that CARMIL negatively regulates NF-κB (Di Prisco et al., 2013). In 
an alternative model that accounts for negative regulation of NF-κB, 
CARMIL removes CP from the barbed ends of filaments, allowing 
it to bind to V-1, thereby preventing V-1 from activating NF-κB 
(Bhattacharya et al., 2006).
SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS
CARMILs are a family of large, multidomain proteins with important 
cellular functions involved in development, differentiation, and dis-
ease. All CARMILs bind to CP and regulate actin assembly in bio-
chemical experiments with purified proteins; in cells, this interaction 
is important for the regulation of actin assembly and actin-based 
motility. CARMILs are often localized to membranes, where they 
regulate membrane-associated actin assembly. The roles of CARMILs 
as CP regulators have been documented relatively well; however, 
regulation of CP by CARMIL is likely to be complementary to and 
distinct from CP regulation by other CPI-motif proteins (Edwards 
et al., 2014). Exciting newer work has begun to uncover novel CP-
independent roles for CARMILs.
CARMIL-family proteins are present in many eukaryotes, with the 
notable exceptions of plants and fungi. Vertebrates have three 
highly conserved genes that encode CARMILs, and these isoforms 
have cellular and biochemical functions that are overlap partially but 
also have distinct functions. For example, only CARMIL2 interacts 
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